• Stature-Specific Knee Replacement
• Calcaneal Trauma System
• Microbial Sealant
  
  

Stature-Specific Knee Replacement

Wright Medical Group, Inc. has announced the launch of its ADVANCE STATURE™ Femoral Components. The latest addition to Wright’s ADVANCE® Knee System, the new ADVANCE STATURE™ components feature a tapered design to address the implant sizing needs of patients with a more narrow knee anatomy or smaller skeletal frame. The company notes that, while “gender-differentiated” knee implant design is much discussed, studies examining factors other than gender have demonstrated that patient size (stature or height), not gender, is a more appropriate determinant of implant needs—that although women are generally smaller than men and may more often require smaller knee implants, patients of either gender may possess a physical stature that would often benefit from a narrower implant design. The ADVANCE STATURE™ femoral components are intended to provide distinct sizing advantages for male or female patients who require more customized sizing and feature a reduced width and contoured anterior flange for optimized patellar tracking. The components are compatible with the ADVANCE® Double-High and Medial-Pivot tibial inserts. Wright's ADVANCE® tibial inserts are designed to allow more natural motion by means of a ball-in-socket mechanism that replicates the stability and freedom of the natural knee. Wright Medical Group stresses that this ball-in-socket feature provides critical implant stability to give patients full confidence in the performance of their "new knee." For more information, contact Wright Medical Technology, Inc. 5677 Airline Road Arlington TN 38002 Phone (901) 867-9971 Fax (901) 867-4390 www.wmt.com

Calcaneal Trauma System

OrthoHelix™ Surgical Designs, Inc. introduces the CalcLock™ Calcaneal Trauma System, a set of implantable, bone fixation plates and screws. The contoured plate design allows for an anatomical fit to the calcaneaus. The plate includes 2 locking screw options positioned to address the most unstable part of the calcaneal fracture as well as a 4.0-mm partially threaded screw to increase compression towards the sustentaculum tali. Both 3.5-mm and 4.0-mm screws are available and include blunt tips to reduce tendon and soft tissue irritation. OrthoHelix is a medical device company developing a comprehensive set of instruments and implants for use in foot/ankle and hand/wrist reconstruction surgery. For more information, contact OrthoHelix™ Surgical Designs, Inc. 1815 West Market Street, Suite 205 Akron, OH 44313 Phone (866) 904-3549 www.orthohelix.com

Microbial Sealant

Kimberly-Clark Health Care has announced the launch of the InteguSeal Microbial Sealant, a microbial barrier designed to reduce the risk of skin flora contamination throughout a surgical procedure. InteguSeal Microbial Sealant uses a proprietary formulation to seal and immobilize pathogens to help protect against migration into an incision. InteguSeal Microbial Sealant has been used in over 15,000 applications during surgical procedures internationally. In late 2006, InteguSeal Microbial Sealant received Food and Drug Administration approval as a class II medical device and is now available for sale in the United States. It is generally accepted that wound contamination by the patient’s endogenous skin flora is a key factor in the development of surgical site infection (SSI), and absolute skin sterilization prior to surgery is not possible.1 InteguSeal Microbial Sealant has a unique mechanism of action that does not promote bacterial resistance and does not need to be removed for suture or closure. Easy to apply and fast-drying, InteguSeal Microbial Sealant can be used with a variety of patient skin preparation treatments and surgical products such as electrocautery, sutures, staples, and wound adhesives. The versatile film bonds to skin surfaces with different curvature, hair-content, or amount or types of flora present. Currently, 2% to 5% of patients undergoing surgery are at risk for SSIs, a major source of morbidity following operative procedures.2 Compared with uninfected patients, those with SSIs remain in hospitals 7 days longer, have a 60% increased probability of admittance to Intensive Care Units, are 5 times more likely to return for continued care within 30 days of discharge, and have double the mortality rate.3 To learn more about InteguSeal Microbial Sealant Kimberly-Clark Corporation, Dept. INT, P.O. Box 2020 Neenah, WI  54957-2020 www.kchealthcare.com/ssi References Hagen KS, Treston-Aurand J. A comparison of two skin preps used in cardiac surgical procedures. AORN J. 1995; 62(3):393-402. Surgical Site Infections; Case For Improvement. IHI.org (Institute of Healthcare Improvement). Barnard B. (2003) Prevention of Surgical Site Infections. Infection Control Today. http://www.infectioncontroltoday.com/articles/341bpract.html.